Avacopan update 24/07/26

27 July 2026
Vifor, which markets avacopan in the UK, has issued a safety communication, in agreement with the MHRA, advising that no new patients should be started on the medicine while the MHRA review is ongoing. Interim guidance pending the MHRA review Services and clinicians are asked to adopt the following...
Read more

Latest kidney centre data now available through UKRR portals

24 July 2026
The UK Renal Registry (UKRR) has updated its Centre Summaries and Audit Standards portals with the latest verified kidney replacement therapy (KRT) data. Used by kidney teams across the UK, these interactive tools provide centre-level data to support local audit, benchmarking and quality improvement...
Read more

New Health Secretary urged to prioritise kidney disease

21 July 2026
The appointment of a new Secretary of State for Health and Social Care marks the next opportunity to make the case for a Kidney Disease Modern Service Framework. Today, the kidney community has written to ensure kidney disease remains firmly on the Government's agenda. The UK Kidney Association has...
Read more

EOIs sought for AKI Special Interest Group

21 July 2026
Expressions of interest are invited for the roles of Clinical Co-Chair of the UKKA Acute Kidney Injury Special Interest Group and Multi-Professional Team (MPT) Co-Chair for the SIG’s Quality Improvement and Implementation Workstream. Clinical co-chair, Acute Kidney Injury, Special Interest Group...
Read more

New Cardiovascular Framework Strengthens Case for Kidney Disease

8 July 2026
The UK Kidney Association welcomes the publication of the Government's new Cardiovascular Disease Modern Service Framework (MSF) , the first in a planned series of MSFs designed to improve care for major health conditions over the next decade and in which chronic kidney disease (CKD) is included as...
Read more

Update on avacopan following regulatory developments

8 July 2026
National clinical leaders for renal and rheumatology services have published an agreed interim position on the use of Tavneos® (avacopan) while the Medicines and Healthcare products Regulatory Agency (MHRA) completes its review. This letter has been issued to Renal Services and Rheumatology Clinical...
Read more

Supportive Care SIG welcomes new Chair

2 July 2026
The UK Kidney Association is pleased to announce the appointment of Professor Helen Hurst as the new Multi-Professional Team (MPT) Co-Chair of the Supportive Care Special Interest Group (SIG). Helen succeeds Karen Jenkins, who is stepping down from the role after helping to lead the SIG alongside...
Read more

Professor Sunil Bhandari awarded William Cullen Medal

2 July 2026
The UK Kidney Association is delighted to share that longstanding member Professor Sunil Bhandari has been awarded the William Cullen Medal by the Royal College of Physicians of Edinburgh (RCPE). The William Cullen Medal recognises "the greatest benefit done to Practical Medicine" and is one of the...
Read more

GLP-1 medications and obesity management in kidney care

24 June 2026
Healthcare professionals working across kidney services are invited to take part in a national survey exploring the use of GLP-1 and other incretin-based therapies in people living with obesity and chronic kidney disease, including kidney failure. Led by Dr Adrian Brown at University College London...
Read more

National dialysis initiative shortlisted for Patient Safety Award

18 June 2026
The DAYLife Shared Haemodialysis Care Mentoring Programme has been shortlisted for the HSJ Patient Safety Awards 2026 in the Patient Safety Education and Training Award category. DAYLife is a national improvement programme delivered in partnership by the UK Kidney Association, Kidney Care UK, the...
Read more